Ran Frenkel
Corporate Officer/Principal at 2P2D Solutions Ltd.
Net worth: 164 566 $ as of 31/03/2024
Profile
Ran Frenkel is the founder of Pfc Pharma Focus Israel Ltd.
which was founded in 2007.
He is currently the Vice President-Business Development at 2P2D Solutions Ltd.
Mr. Frenkel's former positions include Managing Director-EMEA at Clinipace, Inc. from 2011 to 2013, Managing Director at Actelion Pharmaceuticals US, Inc. from 2004 to 2007, and Executive VP-Worldwide Development Operations at Karyopharm Therapeutics, Inc. from 2014 to 2015.
Mr. Frenkel received his undergraduate degree from The Hebrew University of Jerusalem in 1993.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 20/03/2023 | 108,984 ( 0.09% ) | 164 566 $ | 31/03/2024 |
Ran Frenkel active positions
| Companies | Position | Start |
|---|---|---|
2P2D Solutions Ltd.
 2P2D Solutions Ltd. Medical SpecialtiesHealth Technology 2P2D Solutions Ltd. develops an automated drug monitoring system. Its products include ClinicAid and SlimPack. The company was founded by Ofer Baram and Mordechai Peer in 2007 and is headquartered in Tel Aviv, Israel. | Corporate Officer/Principal | 08/03/2011 |
Former positions of Ran Frenkel
| Companies | Position | End |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | 27/07/2022 |
Clinipace, Inc.
 Clinipace, Inc. Miscellaneous Commercial ServicesCommercial Services Clinipace, Inc. provides digital contract research solutions. The firm operates as a digital contract research organization that assists life science firms in developing and executing regulatory strategies, clinical development, and post-approval research. Its service areas encompass clinical monitoring, data management, medical affairs and writing, patient recruitment, study feasibility, and site selection and management. The company was founded by Ronald G. Marks, Christopher K. Porter, and Jeff Lewis Williams in 2003 and is headquartered in Morrisville, NC. | Corporate Officer/Principal | 01/01/2013 |
| Pfc Pharma Focus Israel Ltd. | Founder | 01/01/2011 |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Corporate Officer/Principal | 01/01/2007 |
Training of Ran Frenkel
| The Hebrew University of Jerusalem | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| Private companies | 4 |
|---|---|
Clinipace, Inc.
Clinipace, Inc. Miscellaneous Commercial ServicesCommercial Services Clinipace, Inc. provides digital contract research solutions. The firm operates as a digital contract research organization that assists life science firms in developing and executing regulatory strategies, clinical development, and post-approval research. Its service areas encompass clinical monitoring, data management, medical affairs and writing, patient recruitment, study feasibility, and site selection and management. The company was founded by Ronald G. Marks, Christopher K. Porter, and Jeff Lewis Williams in 2003 and is headquartered in Morrisville, NC. | Commercial Services |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
2P2D Solutions Ltd.
2P2D Solutions Ltd. Medical SpecialtiesHealth Technology 2P2D Solutions Ltd. develops an automated drug monitoring system. Its products include ClinicAid and SlimPack. The company was founded by Ofer Baram and Mordechai Peer in 2007 and is headquartered in Tel Aviv, Israel. | Health Technology |
| Pfc Pharma Focus Israel Ltd. |
- Stock Market
- Insiders
- Ran Frenkel